Register to receive a free Interventional Cardiology Devices Market Report Suite for U.S. 2023-2029 synopsis and brochure Coronary artery disease (CAD) is a multifaceted disease that demands various approaches in terms of diagnosis and treatment options. Devices for the diagnosis and treatment of CAD can be of high volume and low cost or of a relatively low

Globally, the electrophysiology and cardiac ablation catheter markets are growing at a steady pace. Individually, the diagnostic electrophysiology (EP) catheter market value is increasing into 2028, and iData’s analysts predict that the market will reach $3.1 billion. Similarly, the cardiac ablation catheter market is growing and is approaching nearly $5 billion by 2028.  What Segments

Located between the left ventricle and the aorta, sits an essential valve known as the aortic heart valve. Typically, problems associated with the valves are designated as either aortic stenosis and aortic insufficiency. Aortic stenosis occurs when the aortic valve narrows to the point where blood flow is decreased and impeded upon. On the other

WHAT ARE VASCULAR ACCESS DEVICES? A vascular access device is a medical device that’s purpose is to access a patient’s veins and arteries. Additionally, vascular access accessories are used to improve safety and overall performance. Catheters are one of the main vascular access devices used and their indications for use include the administration of drugs,

Throughout iData’s MedSKU analysis on the U.S. pacemaker market, five companies, over 40 brands, and 45 SKUs were analyzed. Despite many market segments included in the MedSKU analysis, this blog focuses and dives deep into three specific segments: Single-Chamber Pacemakers Dual-Chamber Pacemaker  Leadless Pacemakers  iData’s recently completed MedSKU analysis includes an overview of the companies,

As part of a pivotal clinical study, Abbott officially announced the world’s first patient implants of a dual-chamber leadless pacemaker, aptly named AVEIR DRi2i™. This implant of the investigational Aveir™ represents a technological milestone for leadless pacing and is the first seen within the trial.  Patients who experience a slower heart rate are eligible to

iData’s full report suite on the global market for autotransfusion devices includes disposable materials and capital equipment. Disposable devices are typically sold in a kit and can include a wash kit, suction/anticoagulant line and a blood collection reservoir. The capital equipment market includes autotransfusion machines. Overall, the global autotransfusion device market was valued at $224.9

With consideration of pandemic strains on healthcare systems worldwide, seven centers in the U.S., U.K., and Canada have opted to attempt same-day discharge (SDD) with hopes of maintaining transcatheter aortic valve replacement (TAVR) volumes whilst preserving hospital resources during COVID-19 case surges. According to MedPage, after a 17 month trial, 5.9% of 2,100 patients who

When the mitral valve prolapses, blood leaks back into the atrium each time the heart beats. This condition, aptly named degenerative mitral regurgitation (DMR), can be asymptomatic for many patients, but for some it may cause fainting, pain, shortness of breath, and more. According to the University of Maryland, In a year, less than 2

Register to receive the complimentary U.S. Market Report Suite for Cardiac Rhythm Management Devices – MedSuite report synopsis and brochure As it is said in the medical industry: new year, new CPT codes. With each new year, medical professionals are given a handful of changes to the list of CPT codes, and with regard to the

Overall, the global vascular access device market was valued at $4.2 billion, with around 1 billion vascular access devices placed each year. The market size is expected to increase over the forecast period and reach $4.8 billion in 2026. HOW ARE VASCULAR ACCESS DEVICES USED? iData’s global market report for vascular access devices includes both

iData’s analysts work extensively to retrieve data and source both syndicated and custom market research reports. Owing to their in-depth understanding of the markets and first-hand experience with the appropriate data, our analysts have curated a detailed analysis on the market drivers of the Cardiac Surgery Market. With this top-down insight of our global report,

iData’s full report on the Global Interventional Cardiology Market includes in-depth information on the following segments: Coronary Atherectomy Devices Catheters Guidewires Introducer Sheaths Vascular Closure Balloon Inflation CEP Devices Overall, the global pandemic (COVID-19) resulted in a substantial decline in the global interventional cardiology market. The global interventional cardiology market, as most medical device markets,

Market trends for the global Left Atrial Appendage (LAA) Closure Device Market indicate growth over the forecast period and into 2027. Overall, the global LAA market had a valuation of approximately $697 million in 2020. Due to the global COVID-19 pandemic, the LAA market experienced a significant decrease in revenue between 2019 and 2020. Despite

2020 was an unusual year mainly because of the global COVID-19 pandemic, which caused a decrease in the Global Atherectomy Market from 2019 to 2020. While the value of the total atherectomy device market decreased in 2020, due primarily to COVID-19, iData forecasts that the market is expected to grow over the forecast period following

iData’s report on the global central venous catheter (CVC) market includes both acute and chronic CVC’s. In the past, the central venous catheter market suffered extreme consequences after the Joint Commission guidelines recommended that catheters should only be placed in the femoral vein if no other sites are available. This recommendation was due to the

Throughout iData’s MedSKU analysis, six companies and over 30 brands were analyzed within six market segments including IVUS consoles, IVUS catheters, OCT consoles, OCT catheters, FFR consoles, and FFR catheters. Despite many market segments included in the MedSKU analysis, this blog focuses and dives deep into three specific segments: Intravascular Ultrasound (IVUS) Catheters  Fractional Flow

iData’s report on the global peripheral vascular stents market covers bare-metal stents (BMS), covered stents, and drug-eluting stents (DES). In 2018, the drug-eluting stent market suffered extreme consequences after studies demonstrating the late-mortality signal from paclitaxel use within the peripheries were released. Although the FDA released a statement approving the use of paclitaxel devices, many

Canada’s vascular access market includes medical devices with the ability to access a patient’s veins and arteries as well as accessories to improve safety and performance. By 2026, Canada’s vascular access market expects to reach $352.5 million at a CAGR of 2%. Overall, there are many vascular access devices, and iData’s analysis includes a wide

The global coronary balloon catheters market size should keep a positive trajectory, reaching $3.5 billion by 2027, with the drug-eluting market segment representing the majority of the total market. Currently, Boston Scientific, Medtronic, and Philips control the global market share.  What is the global market landscape for coronary balloon catheters? The first devices used in

Overall, the global transcatheter mitral valve repair device market was valued at $763.6 million in 2020, which is a 2.2% increase from $747 million in 2019. This is expected to increase over the forecast period at a CAGR of 16.4% to reach $2.2 billion. What do transcatheter mitral valve repair devices treat? The human heart

The total coronary stent market comprises bare-metal stents, drug-eluting stents, covered stents, and bifurcated stents. Stents can be defined as small mesh tubes inserted into an artery to prevent it from collapsing and keep it open after an angioplasty surgery (percutaneous coronary intervention, or PCI). Following multiple clinical studies that presented evidence of over-stenting in

Market trends for both the global Ventricular Assist Device (VAD) and Intra-aortic Balloon Pump (IABP) markets indicate growth over the forecast period and into 2027. Overall, the global VAD and IABP markets had a combined valuation of approximately $2 billion in 2020. These markets expect to reach a combined value of about $3.2 billion by

Overview Technology, especially when it comes to medical devices, is consistently advancing. As a result, it can be challenging to stay on top of the new procedures, devices, and advancements. If you have ever wanted to learn more about mechanical heart valves, the current and projected growth within this market, and how long they last,

Receive a free Interventional Cardiology Devices Market Report Suite for U.S.  synopsis and brochure iData Research, a leading international market research and consulting firm, has published results from their latest cardiovascular research revealing that there are over 2 million stents implanted per year in the United States. Approximately 1.2 Million of these can be attributed

  Intravascular ultrasound (IVUS) is an imaging technique that can be used as an alternative in peripheral procedures. IVUS provides the physician with a cross-sectional image of the vessel. Specifically, the technique is used in endovascular aneurysm repair (EVAR), thoracic endovascular aneurysm repair (TEVAR), carotid, subclavian, mesenteric, renal, iliac, superficial femoral artery (SFA), popliteal, inferior

Over the past few years, the peripheral vascular device market has seen substantial growth. Driven by forward-pressing research, increased awareness about treatment options, and an aging population in the United States, the total number of procedures performed and, therefore, the total number of devices used, has seen a strong and steady increase. One main disease

Keeping up with the market is hard enough without a looming global pandemic swinging it out of control. Although it is difficult to stay on top of recent trends, it is essential if you want to stay ahead of the market and your competition. Continually tracking trends, identifying who is doing well and why, along

Boston Scientific has announced they entered a definitive agreement to acquire Preventice Solutions Inc., a privately-held company that offers a full portfolio of mobile cardiac health solutions and services, ranging from ambulatory cardiac monitors to cardiac event monitors and mobile cardiac telemetry. The transaction will include an upfront cash payment of $925 million, and up

According to a new cardiac surgery market study by iData Research, the number of cardiac surgeries exceeds 900,000 procedures each year in the United States. The US Cardiac surgery market is growing rapidly driven by the growth of many underlying procedures. The number of cardiac surgery procedures commonly includes: • Coronary Artery Bypass Grafting (CABG)•